Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmic Genetics"
DOI: 10.1080/13816810.2016.1244695
Abstract: ABSTRACT Background: Surgical removal of one or both eyes has been the most common way to treat children with retinoblastoma worldwide for more than 100 years. Ophthalmic artery chemosurgery (OAC) was introduced 10 years ago… read more here.
Keywords: advanced retinoblastoma; artery chemosurgery; ophthalmic artery; eyes advanced ... See more keywords
Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0235016
Abstract: Objective Intravitreal melphalan injections are commonly used in the treatment for intraocular retinoblastoma. This study compares retinal toxicity and ocular survival between two formulations, with and without propylene glycol (Alkeran vs. Evomela, respectively). Methods A… read more here.
Keywords: toxicity; intravitreal melphalan; ocular survival; retinal toxicity ... See more keywords